Learn more

HAFSLUND NYCOMED AS

Overview
  • Total Patents
    63
About

HAFSLUND NYCOMED AS has a total of 63 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United Kingdom, Norway and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are COR THERAPEUTICS INC, ALLELIX BIOPHARMA and DENDREON CORP.

Patent filings per year

Chart showing HAFSLUND NYCOMED ASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Undheim Kjell 21
#2 Kremminger Peter 9
#3 Solbakken Magne 9
#4 Sakariassen Kjell Steinar 8
#5 Agner Erik 7
#6 Lange Meinolf 5
#7 Kjell Undheim 4
#8 Orning Lars 4
#9 Falck-Pedersen Mette Lene 4
#10 Hartmann Michael 3

Latest patents

Publication Filing date Title
WO9535478A1 Apparatus for monitoring overhead electric lines
GB9324691D0 Peptide compounds
GB9314200D0 Peptide compounds
GB9312638D0 Assay
GB9312601D0 Peptides
LTIP607A Peptide compounds, method for the preparation and use thereof
ZA9303866B Peptide compounds
GB9311252D0 Cell growth regualtors
US5583043A Cover slip holder for bilateral and unilateral simulation of thrombogenesis in partly occluded blood vessels and use thereof
GB9114570D0 Improvements in or relating to contrast agents
GB9114565D0 Improvements in or relating to contrast agents
GB9113475D0 Chemical compound
GB9111890D0 Improvements in or relating to contrast agents
GB9106673D0 Improvements in or relating to contrast agents
GB9106686D0 Improvements in or relating to contrast agents
GB9005854D0 Peptide compounds
GB9005855D0 Peptide compounds
US4956344A Method for treatment of lesions in the large intestinal epithelium with a tripeptide